Introduction: Deep vein thrombosis (DVT) among patients with intracerebral hemorrhage (ICH) has not been adequately studied. The published literature contains wide variations in the reported incidence and our knowledge regrading predictive factors and clinical significance of DVT in this patient population is also limited. We performed this retrospective chart review in an attempt to glean more information on this topic. Methods: Based on ICD-9 codes, we identified all patients admitted to a tertiary care hospital between January 2010 and April 2013 who carried a diagnosis of ICH. In order to isolate a population with primary ICH we excluded patients with ICH associated with ischemic stroke, underlying structural anomaly, and those admitted with a different primary diagnosis. Patients with known coagulopathy as well as patients with insufficient recorded data were excluded. Results: The records of 425 patients were initially retrieved. After applying our exclusion criteria we included 282 patients in this study. DVT screening was performed in 95 patients (36%) and was positive in 17 (6%). In 65% of cases thrombosis was limited to the distal veins. The majority of DVT occurred in patients with ipsilateral hemiparesis or quadriparesis (77%). There was a borderline association between Glasgow Coma Scale (GCS) score (p=0.07), obesity (p=0.053), and smoking (p=0.07) and DVT. Hypertension was significantly associated with DVT (p=0.02). None of the patients suffered pulmonary embolism and in-hospital mortality was 18% as in the patients with no DVT. However, mean length of hospital stay was significantly higher among patients who had DVT (25.2 vs. 10.5 days, p<0.01). Variable regimens were used for pharmacologic prophylaxis in 120 (43%) of patients and they were effective in preventing DVT (p=0.024). The use of pharmacologic prophylaxis did not increase between 2010 and 2013. Conclusions: DVT among primary ICH patients may be more prevalent than commonly reported. Hypertension is predictive of DVT, and further factors such as the presence or absence of motor deficits, GCS score, and obesity may prove to be of prognostic value. Pharmacologic prophylaxis is efficacious for DVT prevention in primary ICH patients but concerns for hematoma expansion keep its utilization rates low. DVT is associated with prolonged hospitalization. However, its impact on long-term outcome remains to be elucidated.